175 related articles for article (PubMed ID: 16780807)
21. Ras inhibition by FTS attenuates brain tumor growth in mice by direct antitumor activity and enhanced reactivity of cytotoxic lymphocytes.
Aizman E; Mor A; Levy A; George J; Kloog Y
Oncotarget; 2012 Feb; 3(2):144-57. PubMed ID: 22323550
[TBL] [Abstract][Full Text] [Related]
22. Galectin-3 promotes chronic activation of K-Ras and differentiation block in malignant thyroid carcinomas.
Levy R; Grafi-Cohen M; Kraiem Z; Kloog Y
Mol Cancer Ther; 2010 Aug; 9(8):2208-19. PubMed ID: 20682656
[TBL] [Abstract][Full Text] [Related]
23. Inositol hexaphosphate inhibits growth and induces G1 arrest and apoptotic death of androgen-dependent human prostate carcinoma LNCaP cells.
Agarwal C; Dhanalakshmi S; Singh RP; Agarwal R
Neoplasia; 2004; 6(5):646-59. PubMed ID: 15548374
[TBL] [Abstract][Full Text] [Related]
24. Modulation of protein phosphatase 2A activity alters androgen-independent growth of prostate cancer cells: therapeutic implications.
Bhardwaj A; Singh S; Srivastava SK; Honkanen RE; Reed E; Singh AP
Mol Cancer Ther; 2011 May; 10(5):720-31. PubMed ID: 21393425
[TBL] [Abstract][Full Text] [Related]
25. The Ras-pathway inhibitor, S-trans-trans-farnesylthiosalicylic acid, suppresses experimental allergic encephalomyelitis.
Karussis D; Abramsky O; Grigoriadis N; Chapman J; Mizrachi-Koll R; Niv H; Kloog Y
J Neuroimmunol; 2001 Nov; 120(1-2):1-9. PubMed ID: 11694313
[TBL] [Abstract][Full Text] [Related]
26. Improving Therapeutic Potential of Farnesylthiosalicylic Acid: Tumor Specific Delivery via Conjugation with Heptamethine Cyanine Dye.
Guan Y; Zhang Y; Xiao L; Li J; Wang JP; Chordia MD; Liu ZQ; Chung LW; Yue W; Pan D
Mol Pharm; 2017 Jan; 14(1):1-13. PubMed ID: 26992462
[TBL] [Abstract][Full Text] [Related]
27. Suppression of survivin expression in glioblastoma cells by the Ras inhibitor farnesylthiosalicylic acid promotes caspase-dependent apoptosis.
Blum R; Jacob-Hirsch J; Rechavi G; Kloog Y
Mol Cancer Ther; 2006 Sep; 5(9):2337-47. PubMed ID: 16985068
[TBL] [Abstract][Full Text] [Related]
28. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N
Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210
[TBL] [Abstract][Full Text] [Related]
29. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP.
Engedal N; Korkmaz CG; Saatcioglu F
Oncogene; 2002 Feb; 21(7):1017-27. PubMed ID: 11850819
[TBL] [Abstract][Full Text] [Related]
30. Anticarcinogenic effect of FTY720 in human prostate carcinoma DU145 cells: modulation of mitogenic signaling, FAK, cell-cycle entry and apoptosis.
Permpongkosol S; Wang JD; Takahara S; Matsumiya K; Nonomura N; Nishimura K; Tsujimura A; Kongkanand A; Okuyama A
Int J Cancer; 2002 Mar; 98(2):167-72. PubMed ID: 11857403
[TBL] [Abstract][Full Text] [Related]
31. Novel Ras antagonist blocks human melanoma growth.
Jansen B; Schlagbauer-Wadl H; Kahr H; Heere-Ress E; Mayer BX; Eichler H; Pehamberger H; Gana-Weisz M; Ben-David E; Kloog Y; Wolff K
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14019-24. PubMed ID: 10570191
[TBL] [Abstract][Full Text] [Related]
32. The Ras antagonist S-farnesylthiosalicylic acid induces inhibition of MAPK activation.
Gana-Weisz M; Haklai R; Marciano D; Egozi Y; Ben-Baruch G; Kloog Y
Biochem Biophys Res Commun; 1997 Oct; 239(3):900-4. PubMed ID: 9367867
[TBL] [Abstract][Full Text] [Related]
33. A new functional Ras antagonist inhibits human pancreatic tumor growth in nude mice.
Weisz B; Giehl K; Gana-Weisz M; Egozi Y; Ben-Baruch G; Marciano D; Gierschik P; Kloog Y
Oncogene; 1999 Apr; 18(16):2579-88. PubMed ID: 10353601
[TBL] [Abstract][Full Text] [Related]
34. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.
Kokontis JM; Hay N; Liao S
Mol Endocrinol; 1998 Jul; 12(7):941-53. PubMed ID: 9658399
[TBL] [Abstract][Full Text] [Related]
35. The novel Ras antagonist, farnesylthiosalicylate, suppresses growth of prostate cancer in vitro.
McPherson RA; Conaway MC; Gregory CW; Yue W; Santen RJ
Prostate; 2004 Mar; 58(4):325-34. PubMed ID: 14968433
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins.
Aziz MH; Nihal M; Fu VX; Jarrard DF; Ahmad N
Mol Cancer Ther; 2006 May; 5(5):1335-41. PubMed ID: 16731767
[TBL] [Abstract][Full Text] [Related]
37. Ras chaperones: new targets for cancer and immunotherapy.
Kloog Y; Elad-Sfadia G; Haklai R; Mor A
Enzymes; 2013; 33 Pt A():267-89. PubMed ID: 25033809
[TBL] [Abstract][Full Text] [Related]
38. Chloroquine synergizes with FTS to enhance cell growth inhibition and cell death.
Schmukler E; Wolfson E; Haklai R; Elad-Sfadia G; Kloog Y; Pinkas-Kramarski R
Oncotarget; 2014 Jan; 5(1):173-84. PubMed ID: 24368422
[TBL] [Abstract][Full Text] [Related]
39. Ras inhibitor S-trans, trans-farnesylthiosalicylic acid enhances spatial memory and hippocampal long-term potentiation via up-regulation of NMDA receptor.
Wang Y; Chen T; Yuan Z; Zhang Y; Zhang B; Zhao L; Chen L
Neuropharmacology; 2018 Sep; 139():257-267. PubMed ID: 29578035
[TBL] [Abstract][Full Text] [Related]
40. Targeting of K-Ras 4B by S-trans,trans-farnesyl thiosalicylic acid.
Elad G; Paz A; Haklai R; Marciano D; Cox A; Kloog Y
Biochim Biophys Acta; 1999 Dec; 1452(3):228-42. PubMed ID: 10590312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
